featured
Poziotinib in Previously Treated NSCLC Harboring HER2 Exon 20 Insertion Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial
J. Clin. Oncol 2021 Nov 29;[EPub Ahead of Print], X Le, R Cornelissen, M Garassino, JM Clarke, N Tchekmedyian, JW Goldman, SY Leu, G Bhat, F Lebel, JV Heymach, MA SocinskiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.